Impact of a Prebiotic Food-enriched Diet (PreFED) in Combination With Ipilimumab/Nivolumab Combination Immune Checkpoint Blockade (ICB) in ICB-refractory Melanoma Patients

NCT06250335 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

4

Enrollment

OTHER

Sponsor class

Conditions

ICB-refractory Melanoma

Interventions

OTHER: Prebiotic Food-Enriched Diet
DRUG: Ipilimumab
DRUG: Nivolumab

Sponsor

M.D. Anderson Cancer Center